Filing identity and reporting period
Important issuer mismatch: The supplied 10-Q is for Climate Change Crisis Real Impact I Acquisition Corporation (CLII), a blank-check SPAC, not EVgo Inc. It covers the period from inception on August 4, 2020 through September 30, 2020; it is not an EVgo operating-company filing. The company had not begun operations and had no target business identified in this filing.
Financial results and liquidity
- Revenue: None. The company expected to generate operating revenue only after a business combination.
- Net loss: $1,401, consisting of formation and operating costs; basic and diluted loss per share was reported as $(0.00).
- Cash flow: $1 net cash provided by operating activities; $209,744 provided by financing activities; ending cash was $209,745.
- September 30 balance sheet: Total assets of $715,284, including $209,745 cash and $505,539 deferred offering costs. Total liabilities were $691,685, including a $250,000 related-party promissory note and $2,279 due to a related party. Stockholders’ equity was $23,599.
- Debt and liquidity: No long-term debt was reported. The related-party note and advances were repaid at the October 2 IPO closing. The filing reports no market-risk exposure as of September 30.
- Margins and operating comparisons are not meaningful for this pre-operating company; the filing provides no prior comparable-period results.
Material subsequent event and capital structure
On October 2, 2020, after quarter-end, the company completed an IPO of 23 million units at $10 each, raising $230 million gross, and sold 6.6 million private placement warrants for $6.6 million gross. It placed $230 million in a trust account. Transaction costs were $13.16 million, including $8.05 million of deferred underwriting fees payable only if a business combination is completed. The underwriters fully exercised the over-allotment option.
Outlook, risks, and contingencies
- The company was formed to pursue a business combination and had until October 2, 2022, subject to a possible charter amendment, to complete one. It stated there was no assurance of success.
- Public shareholders may redeem shares in connection with a business combination; if none is completed by the deadline, public shares are to be redeemed from the trust, while warrants may expire worthless.
- Management expected to incur costs while searching for and evaluating a target. It said additional financing might be needed if expenses exceed estimates, redemptions are significant, or funds are insufficient.
- COVID-19 could adversely affect the company’s financial position or target search, but the specific impact was not determinable; no adjustment was recorded.
- The filing reported no legal proceedings, off-balance-sheet arrangements, or material changes to previously disclosed risk factors. Management assessed disclosure controls as effective at a reasonable assurance level.
Key facts for investors to verify
- Confirm the issuer: this is a CLII SPAC filing, not an EVgo 10-Q.
- Review the October 2 IPO closing, trust funding, and offering costs in subsequent filings.
- Assess the business-combination deadline, redemption terms, sponsor interests, and deferred underwriting fee.
- Review warrant terms and potential dilution, including the sponsor’s private placement warrants and founder shares.